TriSalus Life Sciences Financial Overview
TriSalus Life Sciences's market cap is currently $370.74M. The company's EPS TTM is $-0.96; its P/E ratio is -3.62; TriSalus Life Sciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
